Infant Formula Market : Global Industry Analysis 2016 - 2025 and Opportunity Assessment 2026 - 2036

Infant Formula Market Size, Market Forecast and Outlook By FMI

The infant formula market size stood at USD 54.5 million in 2025. Revenue is anticipated to reach USD 59.2 million in 2026 and USD 136.4 million by 2036 at 8.7% CAGR. Powder formula is estimated to hold 75.0% share of formulation in 2026. By end user, household consumers are projected to account for 70.0% share in 2026.

Summary of the Infant Formula Market

• Demand and Growth Drivers
  • Working parents are buying routine nutrition products since daily feeding requires measured and safe preparation.
  • Pediatric allergy cases are raising use of medical nutrition formats within hypoallergenic and digestive support products.
  • Retailers are giving powder formula wider shelf depth as turnover is faster than liquid formats in many channels.
• Product and Segment View
  • Routine nutrition is forecast to account for 60.0% share in 2026, led by daily feeding remaining the central application.
  • Powder formula is expected to lead with 75.0% share through spray-dried and instant powder formats.
  • Offline retail is projected to secure 65.0% share in 2026 as parents prefer visible packs and pharmacist guidance.
• Geography and Competitive Outlook
  • India is projected to expand at 10.9% CAGR by 2036, supported by urban families shifting toward packaged infant nutrition.
  • Germany is forecast at 10.0% CAGR by 2036 due to pharmacy-led purchasing supporting premium and specialty formats.
  • Nestlé and Groupe Danone hold strong positions through early-life nutrition portfolios and medical nutrition depth.
• Analyst Opinion
  • Nandini Roy Choudhury, Principal Consultant at FMI, observes, "I see parents comparing trust signals before price in infant formula. Families first check age stage and safety records. Pediatric advice then shapes medical nutrition choices for allergy and reflux needs. Retailers keep a strong role as many caregivers want a visible pack and quick guidance. Suppliers able to prove clean sourcing and steady powder availability should gain repeat orders during the forecast decade."
• Infant Formula Market Value Analysis
  • Infant formula has shifted from a basic feeding substitute into a regulated nutrition category for daily infant care.
  • Household consumers are expected to raise formula adoption as working parents need reliable feeding support across routine schedules.
  • Powder formula is gaining preference as families seek longer shelf life and easier storage during repeat monthly purchases.
  • Demand is supported by specialty feeding needs as allergies and digestive concerns increase the role of medical nutrition formats.

Infant formula remains important because household consumers require safe nutrition formats for daily feeding and medically guided feeding. Nestlé reported in June 2025 that NAN Sinergity combines probiotics with six human milk oligosaccharides under its NAN brand, helping suppliers support premium powder formula as parents compare gut and immune support claims. Danone reported that its Dairy & Plants Blend baby formula is nutritionally complete and has over half its required protein from soy. Plant-dairy blending gives brands a route to serve vegetarian feeding needs within regulated infant nutrition. The USA Food and Drug Administration stated in December 2024 that manufacturers should notify the agency about infant formula supply interruptions likely to create meaningful disruption. Supply notification pressure is likely to keep manufacturing reliability important. The USA Food and Drug Administration requested information in May 2025 to start reviewing infant formula nutrient requirements. Nutrient review keeps formulation standards central as brands compete in powder and specialty formula.

Infant Formula Market Definition

Infant formula covers commercially manufactured nutrition products used to feed babies and young children. Scope includes standard infant formula, follow-on formula and specialty formula sold in powder or liquid form. Products used only as adult nutrition or general milk powder are outside the revenue scope.

Infant Formula Market Inclusions

Market scope covers commercial infant formula categorized by product type including standard infant formula, follow-on formula and specialty formula. Application scope covers routine nutrition and medical nutrition across household consumers and healthcare institutions. Channel scope covers offline retail, online retail and specialist baby stores. Revenue scope covers 2026 to 2036. Market participants include formula producers, dairy ingredient suppliers, pediatric nutrition specialists, pharmacies, supermarkets, online retailers, hospitals and caregivers.

Infant Formula Market Exclusions

Study scope excludes general dairy powder, toddler snacks and adult nutrition products without infant feeding claims. Children's enteral nutrition is outside core scope unless sold for infant feeding under medical guidance. Children's health supplement products are excluded unless they carry infant formula feeding claims.

Infant Formula Market Research Methodology

• Primary Research: FMI analysts interviewed infant nutrition producers, ingredient suppliers and specialist retailers. Interviews focused on powder format use and caregiver trust checks.
• Desk Research: Desk research used public birth data, regulatory updates and official company publications. Product scope was checked against public infant nutrition portfolios.
• Market Sizing and Forecasting: Forecast work combined research value anchors with channel mix and country-level infant feeding signals.
• Data Validation: Segment shares were checked against household feeding frequency, pharmacy use and powder format economics across major suppliers.

Why is the Infant Formula Market Growing?

• Urban households are buying age-stage formula as working parents need products with measured preparation routines.
• Specialty formula adoption is rising through pediatric advice for infant gut health and reflux management cases.
• Powder formats keep wider retail placement since supermarkets and pharmacies can manage inventory with lower spoilage exposure.

Routine feeding creates the most frequent purchases as caregivers need repeat packs after the first months of birth. United States food assistance data show infant formula rebates totaled about USD 1.6 billion in fiscal 2024 under the Women, Infants, and Children program. Program rebates reflect how single-supplier contracts and retail redemption affect formula volume in a major economy. Suppliers with stable retail supply and compliant labeling earn trust among families who buy formula every month.

Regulatory checks raise the cost of weak quality systems across powder products. In January 2025, the United States Food and Drug Administration issued draft guidance for low-moisture ready-to-eat foods including powdered infant formula. Probiotic infant formula needs tighter environmental control as dry plants can carry contamination risk without visible spoilage. Brands with strong hazard controls can protect shelf access and reduce recall risk.

Market Segmentation Analysis

• Standard infant formula is anticipated to secure 50.0% share in 2026, supported by broad daily feeding uses that sustain larger volumes compared to specialty products.
• Routine nutrition is projected to account for 60.0% share in 2026 due to most caregiver purchases serving everyday feeding needs.
• Household consumers are forecast to account for 70.0% share in 2026, led by families making recurring purchases outside clinical settings.
• Offline retail is expected to secure 65.0% share in 2026 as caregivers value pack checks and store guidance before buying.
• Powder formula is projected to account for 75.0% share in 2026 since shelf-stable formats suit supermarkets and pharmacies.

The market segmentation covers product and application as the main demand views for infant feeding purchase behavior. End use, distribution channel and formulation complete the scope by showing buyer type and buying format. Product segmentation includes standard infant formula, follow-on formula and specialty formula with standard infant formula leading due to routine daily feeding across households. Application scope covers routine nutrition, medical nutrition and growth support with routine nutrition leading through daily feeding needs after early infancy.

End use includes household consumers, healthcare institutions and clinics with household consumers holding the leading use case because of repeat family purchases. Distribution channel segmentation covers offline retail, online retail and specialty baby stores. Offline retail leads because caregivers value shelf access and pharmacist guidance. Formulation covers powder formula, liquid formula and concentrated liquid. Powder formula is favored for storage life and lower handling cost.

Insights into the Standard Infant Formula Product Segment

• Standard infant formula is expected to account for 50.0% share in 2026, influenced by milk-based and soy-based products serving routine feeding needs.
• Cow milk-based products remain central in supermarkets with families seeking familiar nutrition formats before moving into specialty alternatives.

Insights into the Routine Nutrition Application Segment

• Routine nutrition is projected to account for 60.0% share in 2026 due to daily feeding supporting repeat pack purchases across households.
• Pediatric nutrition portfolios reflect age-stage guidance as families compare standard feeding products before clinical formats.

Insights into the Household Consumers End Use Segment

• Household consumers are anticipated to hold 70.0% share in 2026 as daily bottle-feeding decisions mainly occur inside family routines.
• Parents select products by age stage and convenience during early childcare, which causes prepared baby food purchases to overlap with formula purchases.

Insights into the Offline Retail Distribution Channel Segment

• Offline retail is forecast to account for 65.0% share in 2026, led by pharmacies and supermarkets carrying trusted infant nutrition shelves.
• United Kingdom regulators reviewed infant formula and follow-on formula in February 2025 because of price and information concerns.

Insights into the Powder Formula Formulation Segment

• Powder formula is expected to account for 75.0% share in 2026, supported by longer shelf life and lower handling cost for retailers.
• Milk powder supply depth supports powder formula economics as producers seek dry dairy inputs with stable quality and protein control.

Infant Formula Market Drivers, Restraints, and Opportunities

• Working-parent routines are expected to raise age-stage formula adoption as caregivers require measured products for repeat feeding.
• Formula safety rules are anticipated to slow supplier switching since retailers and caregivers avoid brands with weak quality records.
• Specialty nutrition is expected to create prospects as pediatric guidance raises use of products for allergy and digestive needs.

Routine feeding is expected to remain the strongest demand anchor for infant formula, as families buy repeat packs across the first year of life. United States Department of Agriculture Economic Research Service reported in July 2025 that infant formula rebates reached USD 1.6 billion in fiscal 2024 under the Women, Infants, and Children program. Program rebates show how retail contracts shape branded formula volume across a major economy such as the United States. Quality control will keep shaping powder products as formula failures can damage retailer trust and brand recall. In January 2025, United States Food and Drug Administration issued draft guidance for low-moisture ready-to-eat foods including powdered infant formula. Powdered infant formula is named in the guidance, making plant sanitation and environmental control more important for suppliers. Growth prospects favor suppliers with stable supply and compliant labels over brands with weaker plant discipline. Targeted ingredients should support probiotic infant formula as parents compare nutrition claims with pediatric advice.

Voice of Customer and Decision-driver Analysis

Infant formula brand choice is expected to reflect safety assurance and nutrient adequacy. In May 2025, the United States Food and Drug Administration began a nutrient review process for infant formula under Operation Stork Speed. The agency framed the review around safety, reliability and nutritional adequacy for families. Parent preference is likely to shift toward brands able to prove compliant nutrition and stable supply. Retailers should favor suppliers with clean quality records as formula failures can quickly damage consumer trust.

Consumption Occasion and Usage Pattern Analysis

Infant formula adoption is likely to stay aligned with repeat household feeding routines. United States Department of Agriculture Economic Research Service reported in July 2025 that infant formula rebates totaled about USD 1.6 billion in fiscal 2024, covering benefits for an average 1.2 million participants each month. Monthly participation shows how formula buying follows a recurring feeding cycle. Suppliers with reliable retail availability should benefit as caregivers need steady pack access across early infant care.

Regional Analysis

Country	CAGR
India	10.9%
Germany	10.0%
Brazil	9.1%
China	6.8%
Japan	6.5%
United States	4.0%
United Kingdom	2.3%

Source: Future Market Insights analysis, 2026.

Analysis of Infant Formula Market by Key Countries

• India is expected to expand at 10.9% CAGR by 2036, led by urban households and pharmacy access influencing formula adoption.
• Germany is projected to record 10.0% CAGR by 2036 with premium nutrition formats gaining space in regulated retail channels.
• Brazil is forecast to expand at 9.1% CAGR by 2036 as middle-income families raise spending on routine infant feeding products.
• China is expected to advance at 6.8% CAGR by 2036 since premium formula brands continue to serve quality-focused parents.
• Japan at 6.5% CAGR and United States at 4.0% CAGR by 2036 expand through steady replacement purchases and medically guided feeding use. United Kingdom follows at 2.3% CAGR as mature retail penetration limits faster volume gains.

Country performance differs by birth trends, household income and retail trust in regulated infant nutrition. India leads through rising urban purchasing and wider access to packaged baby nutrition. Germany follows as parents favor certified and premium products across pharmacy-led channels. Brazil advances as household spending shifts toward branded formula for daily feeding. China and Japan hold steady through quality-led buying. United States and United Kingdom expand at slower rates as formula use is already more established.

Demand Outlook for Infant Formula in India

Infant formula demand in India is expected to expand at 10.9% CAGR by 2036, supported by urban working families and wider pharmacy distribution. Parents are expected to compare age-stage products more closely as feeding routines become more planned. Powder formula should remain the main purchase format as households value storage life and repeat pack availability. Suppliers with trusted labels and strong retail access should convert more monthly purchases.

• Urban families are buying more measured formula packs as working parents need feeding products integrating fixed routines.
• Pharmacy counters influence brand selection as caregivers often seek guidance before buying infant nutrition products.
• Powder formula fits Indian households through longer shelf life and easier storage during repeat monthly purchases.

Opportunity Analysis of Infant Formula in Germany

The sector in Germany is projected to record 10.0% CAGR by 2036, influenced by parents maintaining strong interest in premium and tightly regulated baby nutrition. Retail buyers are likely to prioritize safety records and clear ingredient claims before expanding shelf space. Specialty formula should gain attention through pediatric advice for allergy and digestive support. Brands with clean compliance records and pharmacy channel depth should hold firmer positions.

• Parents in Germany show higher trust in products that carry clear nutrition labels and strict manufacturing controls.
• Pharmacy-led buying supports specialty formula as caregivers seek advice for allergy and digestion-related feeding needs.
• Premium powder products gain shelf space as retailers prefer brands with stable quality and reliable supply records.

Sales Analysis for Infant Formula in Brazil

Infant formula sales in Brazil are forecast to expand at 9.1% CAGR by 2036 due to middle-income households allocating more spending to packaged infant nutrition. Retail expansion influences wider availability across supermarkets and pharmacies. Routine nutrition products are expected to keep a strong position as caregivers need repeat packs during the first year. Suppliers with affordable premium ranges should gain better access to family buyers.

• Supermarkets support routine formula purchases as families combine infant nutrition buying with regular household shopping trips.
• Branded powder formula gains preference because caregivers seek products that are easy to store and prepare.
• Middle-income consumers are expected to compare pack size and nutrition claims before selecting repeat formula brands.

In-Depth Analysis of Infant Formula in China

Infant formula demand in China is expected to advance at 6.8% CAGR by 2036 since quality assurance and premium positioning continue to guide formula buying. Parents are likely to favor brands with strong safety records and visible product traceability. Domestic and international suppliers are expected to compete around stage-specific products and specialty nutrition claims. Channel strength should remain important as online and offline routes both influence brand choice.

• Parents place high weight on product safety as infant nutrition remains a trust-sensitive purchase category.
• Stage-specific products support repeat purchases as caregivers shift from early feeding to follow-on nutrition.
• Retail and digital channels guide brand discovery as families compare claims before making larger pack purchases.

Demand Outlook for Infant Formula in Japan

Infant formula demand in Japan is forecast at 6.5% CAGR by 2036, driven by mature households continuing to prioritize safety and product reliability. Smaller family sizes may limit volume acceleration. Quality-focused buying promotes revenue growth. Liquid and specialty products can gain adoption in hospitals and convenience-led feeding cases. Suppliers with reliable quality systems and clear nutrition positioning should keep retailer confidence.

• Japanese caregivers favor trusted brands as infant feeding decisions depend heavily on safety and product consistency.
• Specialty nutrition gains attention through pediatric use cases involving allergy support and sensitive digestion.
• Convenience formats can serve travel and hospital feeding needs without replacing powder formula as the core format.

Sales Analysis of Infant Formula in United States

Infant formula demand in the United States is projected to rise at 4.0% CAGR by 2036 as the market remains mature and quality standards stay central. Household consumers support repeat purchases through daily feeding needs. Specialty formula should support revenue expansion as medical and allergy-related feeding cases require more targeted products. Suppliers with stable supply and strong compliance records should defend retail shelf access.

• Repeat household buying supports steady formula revenue as caregivers need consistent pack availability each month.
• Specialty formula gains use when pediatric advice points families toward allergy or reflux management products.
• Retailers favor suppliers with strong quality controls as past supply issues raised buyer sensitivity around availability.

Opportunity Analysis of Infant Formula in United Kingdom

The infant formula sector in the United Kingdom is expected to post 2.3% CAGR by 2036, as mature retail access limits faster expansion. Parents are likely to focus on nutrition clarity and product suitability. Pharmacy and supermarket channels should continue to guide mainstream formula buying. Suppliers are likely to improve performance through clear stage labeling and dependable shelf availability.

• Mature retail penetration keeps volume gains moderate as most caregivers already have access to formula products.
• Brand trust shapes repeat purchases since parents avoid frequent changes in infant feeding products.
• Clear stage labeling supports purchase confidence as caregivers move from newborn formula to follow-on products.

Competitive Landscape and Strategic Positioning

• Competition is concentrated around global infant nutrition groups that compete on stage coverage and medical nutrition strength.
• Nestlé and Groupe Danone hold strong positions through early-life nutrition ranges and broad international retail reach.
• Specialist brands compete through hypoallergenic formula and premium milk proteins and online subscription formats.

Infant formula competition reflects brand trust and evidence behind nutrition claims. Global groups use stage-based portfolios to serve routine feeding from early infancy to follow-on use. Medical nutrition depth gives larger suppliers an advantage in allergy and digestive support. Abbott said in August 2025, Similac 360 Total Care with five human milk oligosaccharides showed clinical benefits in a 2024 study. Clinical proof provides pediatric channels a specific reason to support branded products. Suppliers with firm research evidence are likely to defend pricing against private-label and lower-cost alternatives.

Portfolio control matters more as regulators and parents examine marketing claims more closely. Danone published its baby formula marketing standards in 2024 and expects global implementation by the end of 2025. Clearer marketing rules limit weak claims and put more pressure on channel conduct. Brands that train retail partners are expected to lower compliance risk as online retail expands.

Hypoallergenic formula knowledge supports specialty formula positioning around allergy management. Suppliers that explain protein processing in plain terms are expected to earn stronger pediatric and pharmacy confidence.

Competitive advantage is likely to favor suppliers with wide stage portfolios and credible medical nutrition evidence. Large global groups should hold strong positions through retail access and regulated marketing discipline. Specialist brands can gain share in focused needs such as allergy support if they prove quality and explain product suitability clearly. Winning suppliers are expected to protect trust while giving parents and healthcare channels a clear reason to choose their formula.

Key Companies in the Infant Formula Market

Competition includes global infant nutrition companies, medical formula specialists and regional infant nutrition producers.

• Global Leaders: Nestlé, Groupe Danone and Abbott Nutrition compete with broad stage formula portfolios and international retail access. Nestlé brings NAN and Wyeth coverage across routine nutrition and premium formats. Danone uses Aptamil and Nutricia brands in early-life nutrition. Abbott Nutrition supports Similac and specialty feeding products in hospital and retail channels.
• Specialty Nutrition Players: Mead Johnson Nutrition, The Kraft Heinz Company and Pfizer Inc. participate through pediatric nutrition, medical formula or child nutrition channels. Mead Johnson brings Enfamil and Nutramigen coverage across standard and allergy-led feeding. Kraft Heinz participates through packaged baby nutrition. Pfizer retains relevance through pediatric nutrition history and health-channel recognition.
• Regional Participants: Synutra International, Beingmate Baby & Child Food and Meiji Holdings serve country-specific buyer groups with local production and retail familiarity. Chinese suppliers compete on domestic brand trust and channel access. Meiji serves Japan and Asia through dairy nutrition expertise. Regional brands must prove safety and formula consistency to gain share against global groups.

Competitive Benchmarking: Infant Formula Market

Company	Stage Portfolio Depth	Medical Formula Fit	Channel Trust Reach	Geographic Footprint
Nestlé	High	Strong	High	Global
Groupe Danone	High	High	High	Global
Abbott Nutrition	High	High	Strong	Global
Mead Johnson Nutrition	High	Strong	Strong	Global
The Kraft Heinz Company	Medium	Moderate	Strong	North America and Europe
Synutra International	Medium	Moderate	Medium	China and Asia
Beingmate Baby & Child Food	Medium	Moderate	Medium	China
Meiji Holdings	Medium	Moderate	Strong	Japan and Asia
Friesland Campina	Medium	Moderate	Strong	Europe and Asia
Pfizer Inc.	Low	Strong	High	Global health channels

Source: Future Market Insights competitive analysis, 2026. Ratings reflect relative positioning based on stage portfolio depth, medical formula fit and channel trust reach.

Key Developments in the Infant Formula Market

• In November 2024, Reckitt appointed Dr. Alessio Fasano as chief science and medical officer for Mead Johnson Nutrition. Scientific leadership reinforces Enfamil and Nutramigen development.
• In March 2025, Danone reported that its baby formula marketing standards were published in 2024 and planned for full global implementation by the end of 2025. Responsible marketing controls reinforce stronger retail and healthcare channel discipline.
• In August 2025, Abbott highlighted a 2024 clinical study for Similac 360 Total Care with five human milk oligosaccharides. Clinical evidence reinforces premium formula positioning in pediatric and pharmacy channels.

Key Players in the Infant Formula Market

Global Leaders

• Nestlé
• Groupe Danone
• Abbott Nutrition
• Mead Johnson Nutrition
• The Kraft Heinz Company

Regional and Specialist Players

• Synutra International Inc.
• Beingmate Baby & Child Food Co. Ltd.
• Friesland Campina
• Meiji Holdings Co. Ltd.
• Pfizer Inc.

Report Scope and Coverage

Parameter	Details
Quantitative Units	USD 59.2 million in 2026 to USD 136.4 million in 2036, at 8.7% CAGR
Market Definition	Commercially manufactured infant formula used for routine and medically guided feeding across household and healthcare settings.
By Product	Standard infant formula, follow-on formula, specialty formula
By Application	Routine nutrition, medical nutrition
By End Use	Household consumers, healthcare institutions
By Distribution Channel	Offline retail, online retail
By Formulation	Powder formula, liquid formula
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	United States, United Kingdom, China, India, Germany, Brazil, Japan and 30+ countries
Key Companies Profiled	Nestlé, Groupe Danone, Abbott Nutrition, Mead Johnson Nutrition, Synutra International, Beingmate Baby & Child Food, Friesland Campina, Meiji Holdings and Pfizer
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology using value anchors, segment shares and country feeding activity checks

Source: Future Market Insights, 2026.

Infant Formula Market Breakdown by Product, Application, End Use, Distribution Channel, Formulation, and Region

Infant Formula Market Segmented by Product

• Standard Infant Formula
  • Milk Based Formula
    • Cow Milk Based
    • Goat Milk Based
  • Soy Based Formula
    • Lactose Free Formula
    • Plant Based Formula
• Follow On Formula
  • Stage Two Formula
    • Six To Twelve Months
    • Nutrient Enriched Formula

• • Stage Three Formula
    • Toddler Nutrition

• • • Growth Support Formula
• Specialty Formula
  • Hypoallergenic Formula
    • Extensively Hydrolyzed Formula
    • Amino Acid Based Formula
  • Anti Reflux Formula
    • Thickened Formula
    • Digestive Support Formula
  • Premature Infant Formula
    • High Calorie Formula
    • Clinical Nutrition Formula

Infant Formula Market Segmented by Application

• Routine Nutrition
  • Daily Feeding
    • Home Consumption
    • Daycare Feeding
  • Supplementary Feeding
    • Mixed Feeding
    • Occasional Use
• Medical Nutrition
  • Allergy Management
    • Milk Protein Allergy
    • Lactose Intolerance
  • Digestive Health
    • Colic Management
    • Reflux Management
  • Growth Support
    • Premature Infants
    • Low Birth Weight Infants

Infant Formula Market Segmented by End Use

• Household Consumers
  • Urban Families
    • Working Parents
    • Dual Income Households
  • Rural Families
    • Basic Nutrition Use
    • Supplementary Feeding
• Healthcare Institutions
  • Hospitals
    • Neonatal Care Units
    • Maternity Wards
  • Clinics
    • Pediatric Clinics
    • Nutrition Centers

Infant Formula Market Segmented by Distribution Channel

• Offline Retail
  • Supermarkets And Hypermarkets
    • Large Format Stores
    • Baby Care Sections
  • Pharmacies And Drug Stores
    • Chain Pharmacies
    • Independent Pharmacies
  • Specialty Baby Stores
    • Infant Care Stores
    • Mother And Child Stores
• Online Retail
  • E Commerce Platforms
    • Marketplace Platforms
    • Brand Owned Websites
  • Subscription Services
    • Auto Delivery Plans
    • Parent Membership Programs

Infant Formula Market Segmented by Formulation

• Powder Formula
  • Spray Dried Powder
    • Standard Powder
    • Instant Powder
  • Fortified Powder
    • Vitamin Enriched
    • Mineral Enriched
• Liquid Formula
  • Ready To Feed
    • Single Use Bottles
    • Hospital Use Packs
  • Concentrated Liquid
    • Dilution Required
    • Bulk Packs

Infant Formula Market by Region

• North America
  • United States
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan and Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
  • Rest of South Asia and Pacific
• Middle East and Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Rest of Middle East and Africa

Research Sources and Bibliography

• Abbott. (2025, August 20). With Infant Formula, Innovating Means Getting Ever Closer to Breast Milk. Abbott.
• Competition and Markets Authority. (2025, February 14). Infant Formula and Follow-on Formula Market Study. GOV.UK.
• Danone. (2025, March). Danone Responsible Marketing of Baby Formula: Report 2024. Danone.
• Federal Statistical Office. (2025, July 17). Decline in Fertility Rate Slowed Significantly in 2024. Destatis.
• Government Accountability Office. (2025, January 14). WIC Infant Formula: Single-Supplier Competitive Contracts Reduce Program Costs and Modestly Increase Retail Prices. GAO.
• National Bureau of Statistics of China. (2026, February 28). Statistical Communiqué of the People’s Republic of China on the 2025 National Economic and Social Development. National Bureau of Statistics of China.
• Nestlé. (2025, June 2). Nestlé’s Groundbreaking Sinergity Is Going Global. Nestlé.
• Nestlé. (2026, February 19). Full-Year Results 2025 and Strategic Update. Nestlé.
• Office for National Statistics. (2025, July 1). Births in England and Wales: 2024. ONS.
• Press Information Bureau. (2025, September 25). Release of Publication “Children in India 2025”. PIB.
• Reckitt. (2024, November 25). Dr. Alessio Fasano Appointed as Chief Science and Medical Officer. Reckitt.
• USA Department of Agriculture, Economic Research Service. (2025, July 22). WIC Program. USDA ERS.
• USA Food and Drug Administration. (2024, December 2). FDA Issues Guidance on Notifying FDA of a Permanent Discontinuance in the Manufacture or an Interruption of the Manufacture of an Infant Formula. FDA.
• USA Food and Drug Administration. (2025, January 6). Draft Guidance for Industry: Establishing Sanitation Programs for Low-Moisture Ready-to-Eat Human Foods and Taking Corrective Actions Following a Pathogen Contamination Event. FDA.
• USA Food and Drug Administration. (2025, May 13). HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula. FDA.
• USA Food and Drug Administration. (2025, May 14). Infant Formula Nutrient Requirements; Request for Information. Federal Register.
• USA Food and Drug Administration. (2026, February 26). Information for infant formula manufacturers and retailers.
• USA Food and Drug Administration. (2026, April 29). FDA’s infant formula product testing results.

Bibliography is provided for reader reference and uses primary government, regulatory, official trade body or official company publications.

This Report Answers

• What is the current and future value of the infant formula market from 2026 to 2036?
• What CAGR is expected for the infant formula market during the forecast period?
• Which product segment is projected to lead infant formula market demand in 2026?
• Which application segment is expected to hold the strongest share in infant formula market demand?
• What factors are driving adoption of infant formula across household consumers?
• How do powder formulation and offline retail channels affect supplier selection in this sector?
• Which countries are expected to grow fastest in the infant formula market by 2036?
• Which companies are positioned across medical formula and retail-backed formula sales?
• How does FMI define the infant formula market revenue scope?
• What forecasting approach was used to estimate infant formula market demand from 2026 to 2036?